| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 5,750 | 7,000 | 28.10. |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 35,000 | 6 | |||
| 33,000 | 33 | |||
| 9,500 | 175 | |||
| 8,550 | 450 | |||
| 6,500 | 602 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/88q.htm [/URL] | ||||
| 602 | 6,200 | |||
| 700 | 4,740 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 1.302 | 0,972 | 1.266 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 16:00:20 | 6,350 | 500 |
| Tagesumsatz Xetra | 0,000 0,00 % | 500 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.10. | 4basebio Plc - Result of Retail Offer | 413 | PR Newswire | 4basebio Plc - Result of Retail OfferPR NewswireLONDON, United Kingdom, October 21
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, TO US PERSONS... ► Artikel lesen | |
| 20.10. | 4basebio Plc - Posting of Circular and Notice of General Meeting | 346 | PR Newswire | 4basebio Plc - Posting of Circular and Notice of General MeetingPR NewswireLONDON, United Kingdom, October 20
20 October 2026
4basebio PLC
("4basebio" or the "Company")
Posting... ► Artikel lesen | |
| 15.10. | TRADING UPDATES: 4basebio fundraise; Geo Exploration secures grants | 4 | Alliance News | ||
| 15.10. | 4basebio Plc - Proposed Retail Offer | 574 | PR Newswire | 4basebio Plc - Proposed Retail OfferPR NewswireLONDON, United Kingdom, October 15
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, TO US PERSONS... ► Artikel lesen | |
| 4BASEBIO Aktie jetzt für 0€ handeln | |||||
| 15.10. | 4basebio Plc - Results of Capital Raise | 563 | PR Newswire | 4basebio Plc - Results of Capital RaisePR NewswireLONDON, United Kingdom, October 15
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Mi | EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Group (EN) | EQS Voting Rights Announcement: Evotec SE
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| Mi | EQS-NVR: Evotec SE: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Group (DE) | EQS Gesamtstimmrechtsmitteilung: Evotec SE
/ Veröffentlichung der Gesamtzahl der Stimmrechte
Evotec SE: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG mit dem... ► Artikel lesen | |
| Mi | Genmab A/S: Genmab Announces Statistically Significant, Clinically Meaningful Improvement in Overall Survival and Objective Response with Petosemtamab Combination at First Interim Analysis in First-Line R/M Patients with PD-L1+ Head and Neck Cancer | Business Wire | Phase 3 LiGeR-HN1 trial of Petosemtamab in combination with pembrolizumab versus pembrolizumab alone met both primary endpoints, reducing the risk of death by 50% in patients with PD-L1 positive... ► Artikel lesen | |
| Mi | DBV Technologies S.A.: DBV Technologies Reports Third Quarter 2026 Financial Results and Business Update | GlobeNewswire (Europe) | Châtillon, France, October 28, 2026
DBV Technologies Reports Third Quarter 2026 Financial Results and Business Update
Submitted the Biologics License Application to U.S. FDA for the VIASKIN... ► Artikel lesen | |
| Mi | SenesTech: SeneTech: Sandstrom Partners Hired As Strategic Advisor on Marketing and Branding | JCN Newswire | Portland-Based Experts on Brand and Marketing Strategy Will Help SenesTech Pursue E-Commerce and B2B Sales-Growth Opportunities.SURPRISE, Ariz., Oct 28, 2026 - (ACN Newswire) - SenesTech, Inc. (NASDAQ:... ► Artikel lesen |